Related Experiment Videos

Transcutaneous CO2 tension effects of clonidine in paediatric caudal analgesia

A Dupeyrat1, E Goujard, J Muret

  • 1Department of Anesthesiology and Intensive Care Medecine, Hôpital de Bicêtre, Université Paris-Sud, Le Kremlin Bicêtre, France.

Paediatric Anaesthesia
|April 29, 1998
PubMed

Insights

Clonidine added to bupivacaine for pediatric caudal analgesia did not cause respiratory depression. This study found no significant increase in transcutaneous CO2 tension (tcPCO2) in children receiving clonidine.

Area of Science:

  • Pediatric Anesthesiology
  • Pharmacology
  • Pain Management

Background:

  • Clonidine is used with bupivacaine for analgesia in adults, with minimal respiratory effects.
  • Previous studies have not quantified the respiratory effects of clonidine in pediatric patients.

Purpose of the Study:

  • To investigate the safety and efficacy of adding clonidine to bupivacaine for caudal analgesia in children.
  • To assess the impact of clonidine on respiratory function and sedation levels in pediatric patients.

Main Methods:

  • A double-blind study randomized 24 children (9 months to 7 years) into two groups.
  • One group received bupivacaine with clonidine (1 microgram.kg-1), the other received bupivacaine with normal saline (placebo).
  • Patients were monitored for 3 hours post-procedure for respiratory rate, transcutaneous CO2 tension (tcPCO2), and sedation scores.

Main Results:

  • No significant differences in mean tcPCO2 or respiratory rate were observed between the clonidine and placebo groups.
  • No apnea or oxygen desaturation below 97% occurred in either group.
  • Patients in the clonidine group exhibited prolonged sedation, but without adverse respiratory effects.

Conclusions:

  • Clonidine (1 microgram.kg-1) combined with bupivacaine for caudal analgesia in children is safe regarding respiratory function.
  • The addition of clonidine provides prolonged sedation without increasing tcPCO2 in pediatric patients.

Related Concept Videos